Skip to main content
Clinical Trials/JPRN-jRCT1030210558
JPRN-jRCT1030210558
Recruiting
N/A

Examination of hemodynamics of liver tumors such as hepatocellular carcinoma and hepatic parenchyma using intra-arterial contrast-enhanced ultrasonography

Shiozawa Kazue0 sites50 target enrollmentJanuary 19, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
hepatocellular carcinoma, liver cirrhosis
Sponsor
Shiozawa Kazue
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shiozawa Kazue

Eligibility Criteria

Inclusion Criteria

  • Based on the Evidence\-based Clinical Practice Guidelines for hepatocellular carcinoma developed by the
  • Japan Society of Hepatology, the cases in which transarterial chemoembolization or hepatic arterial infusion
  • chemotherapy for hepatocellular carcinoma were selected and consent was obtained for this study.

Exclusion Criteria

  • Based on the same guidelines, the cases that are not indicated for transarterial chemoembolization or hepatic arterial infusion chemotherapy for hepatocellular carcinoma and for which consent cannot be obtained for this study.
  • Excludes minors.

Outcomes

Primary Outcomes

Not specified

Similar Trials